Last reviewed · How we verify

NCT04573075: GI_versus_LI

Ghost Ileostomy (GI) Versus Loop Ileostomy (LI) After Colorectal Resections

Completed NA Last updated 19 November 2024
What this trial tests

NA trial testing Ghost ileostomy in Colorectal Surgery in 257 participants. Completed in 20 March 2022.

Timeline
31 January 2019
Primary endpoint
20 March 2022
20 March 2022

Quick facts

Lead sponsorEvangelisches Klinikum Köln Weyertal gGmbH
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment257
Start date31 January 2019
Primary completion20 March 2022
Estimated completion20 March 2022
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Evangelisches Klinikum Köln Weyertal gGmbH

Who can join

18 and older, any sex, with Colorectal Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Ghost Ileostomy (GI) as an alternative to a diverting protective Loop Ileostomy (LI) after colorectal resection is offered the patients at risk preoperatively. A GI is only applied in cases, who would receive a LI otherwise.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Ghost Ileostomy: Safe and Cost-effective Alternative to Ileostomy After Rectal Resection for Deep Infiltrating Endometriosis.
    Hernández AV, Otten J, Christ H, Ulrici C, et al · · 2022 · cited 3× · PMID 35478159 · DOI 10.21873/invivo.12829

Verify or expand the search:

Other trials of Ghost ileostomy

Trials testing the same drug.

Other recruiting trials for Colorectal Surgery

Currently open trials in the same condition.

Other Evangelisches Klinikum Köln Weyertal gGmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04573075.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing